These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 28064112)
1. Ultra-short screening instruments for major depressive episode and generalized anxiety disorder in epilepsy: The NDDIE-2 and the GAD-SI. Micoulaud-Franchi JA; Bartolomei F; McGonigal A J Affect Disord; 2017 Mar; 210():237-240. PubMed ID: 28064112 [TBL] [Abstract][Full Text] [Related]
2. Rapid detection of generalized anxiety disorder and major depression in epilepsy: Validation of the GAD-7 as a complementary tool to the NDDI-E in a French sample. Micoulaud-Franchi JA; Lagarde S; Barkate G; Dufournet B; Besancon C; Trébuchon-Da Fonseca A; Gavaret M; Bartolomei F; Bonini F; McGonigal A Epilepsy Behav; 2016 Apr; 57(Pt A):211-216. PubMed ID: 26994447 [TBL] [Abstract][Full Text] [Related]
3. Examining brief and ultra-brief anxiety and depression screening methods in a real-world epilepsy clinic sample. Munger Clary HM; Wan M; Conner K; Brenes GA; Kimball J; Kim E; Duncan P; Snively BM Epilepsy Behav; 2021 May; 118():107943. PubMed ID: 33839449 [TBL] [Abstract][Full Text] [Related]
4. One step closer to a global tool for rapid screening of major depression in epilepsy: validation of the French NDDI-E. Micoulaud-Franchi JA; Barkate G; Trébuchon-Da Fonseca A; Vaugier L; Gavaret M; Bartolomei F; McGonigal A Epilepsy Behav; 2015 Mar; 44():11-6. PubMed ID: 25597527 [TBL] [Abstract][Full Text] [Related]
5. Screening for depression in youth with epilepsy: Psychometric analysis of NDDI-E-Y and NDDI-E in a French population. Viellard M; Villeneuve N; Milh M; Lépine A; Micoulaud-Franchi JA; McGonigal A Epilepsy Behav; 2019 Sep; 98(Pt A):19-26. PubMed ID: 31299528 [TBL] [Abstract][Full Text] [Related]
6. Validation of the generalized anxiety disorder-7 in people with epilepsy: a MEPSY study. Seo JG; Cho YW; Lee SJ; Lee JJ; Kim JE; Moon HJ; Park SP Epilepsy Behav; 2014 Jun; 35():59-63. PubMed ID: 24798411 [TBL] [Abstract][Full Text] [Related]
7. Evaluating quality of life in epilepsy: The role of screening for adverse drug effects, depression, and anxiety. Micoulaud-Franchi JA; Bartolomei F; Duncan R; McGonigal A Epilepsy Behav; 2017 Oct; 75():18-24. PubMed ID: 28818810 [TBL] [Abstract][Full Text] [Related]
8. Does presence of metabolic syndrome impact anxiety and depressive disorder screening results in middle aged and elderly individuals? A population based study. Butnoriene J; Steibliene V; Saudargiene A; Bunevicius A BMC Psychiatry; 2018 Jan; 18(1):5. PubMed ID: 29310620 [TBL] [Abstract][Full Text] [Related]
9. Psychometric properties of the Lithuanian version of the NDDI-E in persons with epilepsy and suicidal ideation. Puteikis K; Mameniškienė R Epilepsy Behav; 2022 Nov; 136():108913. PubMed ID: 36155364 [TBL] [Abstract][Full Text] [Related]
10. Validation of the Russian version of neurological disorders depression inventory for epilepsy (NDDI-E). Zinchuk M; Kustov G; Pashnin E; Gersamia A; Rider F; Yakovlev A; Guekht A Epilepsy Behav; 2020 Dec; 113():107549. PubMed ID: 33246233 [TBL] [Abstract][Full Text] [Related]
11. Screening for epilepsy-specific anxiety symptoms: French validation of the EASI. Micoulaud-Franchi JA; Kotwas I; Arthuis M; Soncin L; Rontani P; Daquin G; Cermolacce M; Bartolomei F; McGonigal A Epilepsy Behav; 2022 Mar; 128():108585. PubMed ID: 35180578 [TBL] [Abstract][Full Text] [Related]
12. Validation of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) Serbian version. Ristić AJ; Pjevalica J; Trajković G; Parojčić A; Mihajlović A; Vojvodić N; Baščarević V; Popović T; Janković S; Sokić D Epilepsy Behav; 2016 Apr; 57(Pt A):1-4. PubMed ID: 26900772 [TBL] [Abstract][Full Text] [Related]
13. Reliability and validity of the Taiwanese version of the Neurological Disorders Depression Inventory for Epilepsy (Tw-NDDI-E). Shih YC; Chou CC; Lu YJ; Chou YH; Yu HY Seizure; 2020 Oct; 81():53-57. PubMed ID: 32745948 [TBL] [Abstract][Full Text] [Related]
14. Screening for depression in people with epilepsy: comparative study among neurological disorders depression inventory for epilepsy (NDDI-E), hospital anxiety and depression scale depression subscale (HADS-D), and Beck depression inventory (BDI). de Oliveira GN; Lessa JM; Gonçalves AP; Portela EJ; Sander JW; Teixeira AL Epilepsy Behav; 2014 May; 34():50-4. PubMed ID: 24681386 [TBL] [Abstract][Full Text] [Related]
15. Reliability and validity of the Korean version of the Neurological Disorders Depression Inventory for Epilepsy (K-NDDI-E). Ko PW; Hwang J; Lim HW; Park SP Epilepsy Behav; 2012 Dec; 25(4):539-42. PubMed ID: 23153718 [TBL] [Abstract][Full Text] [Related]
16. Validation of rapid suicidality screening in epilepsy using the NDDIE. Mula M; McGonigal A; Micoulaud-Franchi JA; May TW; Labudda K; Brandt C Epilepsia; 2016 Jun; 57(6):949-55. PubMed ID: 27012840 [TBL] [Abstract][Full Text] [Related]
17. Validation of the Chinese version of the Neurological Disorders Depression Inventory for Epilepsy (C-NDDI-E) in West China. Tong X; An D; Lan L; Zhou X; Zhang Q; Xiao F; Park SP; Kanemoto K; Kanner AM; Zhou D Epilepsy Behav; 2015 Jun; 47():6-10. PubMed ID: 26004785 [TBL] [Abstract][Full Text] [Related]
18. Validation of the Neurological Disorders Depression Inventory for Epilepsy (NDDIE) as a rapid suicidality screening tool in Chinese people with epilepsy. Li Q; Zhu LN; Wang HJ; Lin X; Xu D; Chen D; Zhang Y; Liu L Epilepsy Behav; 2019 May; 94():216-221. PubMed ID: 30974350 [TBL] [Abstract][Full Text] [Related]
19. Validation of the Generalized Anxiety Disorder-7 (GAD-7) among Chinese people with epilepsy. Tong X; An D; McGonigal A; Park SP; Zhou D Epilepsy Res; 2016 Feb; 120():31-6. PubMed ID: 26709880 [TBL] [Abstract][Full Text] [Related]
20. Not always that EASI: Validating the Russian version of the epilepsy anxiety survey instrument and its brief counterpart. Zinchuk M; Kustov G; Pashnin E; Gersamia A; Rider F; Voinova N; Popova S; Sviatskaia E; Yakovlev A; Guekht A Epilepsy Behav; 2022 Aug; 133():108801. PubMed ID: 35753109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]